Pagina 2 - I migliori medici per il trattamento di Tumori neuroendocrini del pancreas - TOP-82 medici

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dirige la Divisione di Oncologia Medica presso il Sourasky Medical Center di Israele, uno dei principali ospedali universitari del paese.

• Specializzato in medicina interna e oncologia medica presso lo Sheba Medical Center
• Possiede una laurea presso l'Università Ben Gurion del Negev
• Parla fluentemente inglese, facilitando le consultazioni internazionali

Il Dr. Serkan Keskin è un oncologo pluripremiato che ha eseguito oltre 1.100 trattamenti oncologici. Si specializza in oncologia medica presso il Memorial Şişli Hospital.

• Oltre 28 anni di esperienza in oncologia medica e medicina interna.
• Ha completato la specializzazione in oncologia medica presso l'Istituto di Oncologia dell'Università di Istanbul.
• Si è classificato al 1º posto in Turchia nell'esame di abilitazione nazionale per l'oncologia medica.
• È membro delle principali società internazionali di oncologia, tra cui ASCO e ESMO.
• Ha pubblicato 42 articoli su riviste mediche internazionali.

La professoressa Yesim Yildirim è specializzata in tumori neuroendocrini pancreatici con oltre 80 pubblicazioni e coautrice di manuali sul trattamento del cancro.

• Membro della European Society of Medical Oncology (ESMO)
• Esperta in immunoterapia oncologica e terapie mirate
• Professoressa presso l'Università Halic, dove guida i futuri oncologi
• Ha completato una formazione avanzata presso il Rambam Medical Centre e il Mount Vernon Cancer Center

Il Professor Şeref Kömürcü è un oncologo mammario certificato ECFMG e ESMO con oltre 20 anni di esperienza. Si specializza in tumori solidi, cancro al seno, cancro colorettale e trattamento del cancro ai polmoni e, nel corso della sua carriera, ha ricoperto incarichi accademici e di ricerca. È membro di diverse organizzazioni professionali.

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Endocrinologo

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Leader dell'Iniziativa Nazionale Israeliana di Medicina Genomica – il Dr. Raphael è specializzato in profilazione genomica avanzata per i tumori neuroendocrini pancreatici presso il Sourasky Medical Center.

• Docente senior presso la Facoltà di Medicina dell'Università di Tel Aviv
• Ricercatore principale per numerosi studi clinici in oncologia
• Esperto in biopsie liquide e profilazione genomica complessiva dei tumori
• Membro della Società Europea di Oncologia Medica e dell'IASLC

Il Prof. Christoph Zielinski ha fondato il Comprehensive Cancer Center di Vienna, leader nei trattamenti oncologici personalizzati che combinano l'immunoterapia e la biologia tumorale.

• Specializzato in ematologia e oncologia medica da oltre 40 anni
• Dirige l'International Oncology Center presso il Wiener Privatklinik
• Ex presidente del Central European Cooperative Oncology Group
• Pioniere nelle terapie oncologiche individualizzate basate sulla profilazione molecolare

Primario in un centro oncologico interdisciplinare certificato – Il Dr. Fox è specializzato in tumori neuroendocrini pancreatici con un focus su diagnostica molecolare e terapie mirate.

• Oltre 15 anni di esperienza in oncologia ed ematologia
• Specializzato in genetica – migliora i piani di trattamento personalizzati
• Ricercatore attivo in biologia molecolare per terapie oncologiche
• Membro di società oncologiche tedesche e americane

Il professor Keil è specializzato in tecniche avanzate di imaging per i tumori neuroendocrini pancreatici presso l'Academic Hospital Solingen.

• Laureato con lode presso la Julius-Maximilians-Universität Würzburg
• Esperto in MRI, TC e ecografia per interventi complessi
• Primario di Radiologia Diagnostica e Interventistica dal 2022
• Formatosi sotto la guida del rinomato professor Rolf W. Günther ad Aquisgrana

La Prof.ssa Elke Jaeger è una delle principali oncologhe in Germania, riconosciuta dalla rivista Focus per oltre 20 anni. Dirige il reparto di Oncologia ed Ematologia presso la Nordwest Clinic.

• 38 anni di esperienza in oncologia
• Ha eseguito oltre 1.100 procedure oncologiche
• Membro della commissione di esperti dell'EORTC
• Pubblicazioni citate in oltre 7.000 fonti scientifiche
• Specializzata in sarcomi e tumori neuroendocrini

Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.

Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.